LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 281 of 535
Next
>>
>
7001 to 7025 of 13356 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	Imatinib	10	uM	LJP6	2	N13	72	hr	1097	3532	3713	0.9511	0.9438
BT-20	Imatinib	10	uM	LJP6	3	N13	72	hr	1097	3423	3696	0.9260	0.9142
BT-20	NVP-TAE684	0.04	uM	LJP6	1	K18	72	hr	1097	3798	3610	1.0519	1.0598
BT-20	NVP-TAE684	0.04	uM	LJP6	2	K18	72	hr	1097	3756	3713	1.0114	1.0129
BT-20	NVP-TAE684	0.04	uM	LJP6	3	K18	72	hr	1097	3806	3696	1.0296	1.0336
BT-20	NVP-TAE684	0.12	uM	LJP6	1	K17	72	hr	1097	3545	3610	0.9818	0.9788
BT-20	NVP-TAE684	0.12	uM	LJP6	2	K17	72	hr	1097	3589	3713	0.9664	0.9615
BT-20	NVP-TAE684	0.12	uM	LJP6	3	K17	72	hr	1097	3905	3696	1.0564	1.0636
BT-20	NVP-TAE684	0.37	uM	LJP6	1	K16	72	hr	1097	3214	3610	0.8902	0.8691
BT-20	NVP-TAE684	0.37	uM	LJP6	2	K16	72	hr	1097	3553	3713	0.9567	0.9503
BT-20	NVP-TAE684	0.37	uM	LJP6	3	K16	72	hr	1097	3684	3696	0.9966	0.9962
BT-20	NVP-TAE684	1.11	uM	LJP6	1	K15	72	hr	1097	2936	3610	0.8132	0.7732
BT-20	NVP-TAE684	1.11	uM	LJP6	2	K15	72	hr	1097	2822	3713	0.7599	0.7109
BT-20	NVP-TAE684	1.11	uM	LJP6	3	K15	72	hr	1097	3072	3696	0.8311	0.7996
BT-20	NVP-TAE684	3.33	uM	LJP6	1	K14	72	hr	1097	1463	3610	0.4052	0.1823
BT-20	NVP-TAE684	3.33	uM	LJP6	2	K14	72	hr	1097	1398	3713	0.3764	0.1477
BT-20	NVP-TAE684	3.33	uM	LJP6	3	K14	72	hr	1097	1931	3696	0.5224	0.3807
BT-20	NVP-TAE684	10	uM	LJP6	1	K13	72	hr	1097	1057	3610	0.2928	-0.0215
BT-20	NVP-TAE684	10	uM	LJP6	2	K13	72	hr	1097	1024	3713	0.2757	-0.0385
BT-20	NVP-TAE684	10	uM	LJP6	3	K13	72	hr	1097	981	3696	0.2654	-0.0619
BT-20	CGP60474	0.04	uM	LJP6	1	G06	72	hr	1097	679	3610	0.1881	-0.2437
BT-20	CGP60474	0.04	uM	LJP6	2	G06	72	hr	1097	781	3713	0.2103	-0.1758
BT-20	CGP60474	0.04	uM	LJP6	3	G06	72	hr	1097	712	3696	0.1926	-0.2187
BT-20	CGP60474	0.04	uM	LJP5	1	F06	72	hr	1097	3146	3735	0.8423	0.8149
BT-20	CGP60474	0.04	uM	LJP5	2	F06	72	hr	1097	3013	3877	0.7770	0.7413

|<
<<
Previous
Page 281 of 535
Next
>>
>
7001 to 7025 of 13356 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)